<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is characterised by rapid <z:hpo ids='HP_0003674'>onset</z:hpo> thromboses, often resistant to conventional <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment, and resulting in life threatening multiple organ dysfunction </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis of catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> may be difficult, predominantly due to its frequently atypical presentation </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of a 35-year-old female who presented with a <z:e sem="disease" ids="C0030297" disease_type="Neoplastic Process" abbrv="">pancreatic tumour</z:e> and extensive thromboses </plain></SENT>
<SENT sid="3" pm="."><plain>Following a storm of ischemic events due to thrombotic occlusions in spite of therapeutic <z:chebi fb="5" ids="28304">heparin</z:chebi> dose, the suspicion of catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> emerged </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was successfully treated with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, immunoglobulins, plasmapheresis and rituximab </plain></SENT>
<SENT sid="5" pm="."><plain>The present report shows that the use of the diluted Russell's viper venom time can be helpful in providing additional information on the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> antibody status, allowing careful monitoring of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> conversion and hence response to therapy </plain></SENT>
</text></document>